Study to Assess Satisfaction in Patients Treated With Copaxone®

Study Title

Study to Assess Medication Satisfaction in Patients With Relapsing Remitting Multiple Sclerosis Treated With Copaxoneֲ®

Teva Identifier

TV44400-CNS-40083 | 2015-000922-12

ClinicalTrials.gov Identifier

NCT02499900

Study Status

Completed

Trial Condition(s)

Multiple Sclerosis

Interventions

Drug: Copaxoneֲ®

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years and older

Trial Duration

August 10, 2015 - June 2, 2017

Phase

Phase 4

Study Type

Interventional